Get Lucky With 10 Saint Patrick’s Day ETFs
Well folks, it’s that special time of the year on Saturday: the green revolution, the grand day of Guinness, the celebration of corn…
PJP
Direxion Resuscitates Leveraged Pharmaceutical ETF
Direxion has revived one of its previously shuttered leveraged ETF ideas and increased the stakes on its original design. On Wednesday, Direxion…
Biotech, Pharma ETFs Leave Pricing Drama Behind
Biotechnology and pharmaceutical ETFs have rallied in recent weeks as drug pricing concerns wane and investors look to the opportunity of this…
Write A Prescription For This Pharma ETF
Pharmaceuticals stocks and exchange traded funds are performing well this year, but some pharmaceuticals ETFs are lagging the performances turned in by…
How a New SCOTUS Ruling Could Affect Pharma ETFs
The VanEck Vectors Generic Drugs ETF (NasdaqGM: GNRX) traded slightly higher Tuesday after the U.S. Supreme Court issued what some industry observers…
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions…
Look to These Sector ETFs in Case of an Election Day Surprise
Heading toward election day, polling surveys and many market watchers anticipate Democrat Hillary Clinton to win the presidential race. However, Republican Donald…
Finding Pharmaceuticals ETFs With Rebound Potential
Like other healthcare exchange traded funds (ETFs), dedicated pharmaceuticals ETFs are struggling this year. While prescription drug sales, such as cialis professional…
The Best Performing ETFs Since the Financial Downturn
Slow and steady value and conservative sectors are leading market gains RPV was best performing non-leveraged ETF across various Morningstar style categories …
Major Pharma Merger Boosts ETFs
Pharmaceuticals giant Pfizer (NYSE: PFE) is in talks to acquire specialty drugmaker Allergan (NYSE: AGN) in what may be the biggest mergers…
Political Placebo: Pharma Regulation
Rare are the investments that can deliver staggering returns over multiple years or even a decade. The PowerShares Dynamic Pharmaceuticals Portfolio (NYSEArca:…
A Long-Term Healthcare Winner
Some stocks and exchange traded funds cobble together a few months, maybe a year or two of solid gains before falling off.…
A Powerful Pharma ETF
Amid a flurry of industry consolidation, among other factors, the health care sector is once again on fire in 2015 with each…
M&A Activity Will Support Pharma ETFs Through Rising Rate Environment
Even if the Federal Reserve begins hiking interest rates later this year, the healthcare sector, notably pharmaceutical stocks and related exchange traded…